PIONERE Trademark

Trademark Overview

On Thursday, May 21, 2009, a trademark application was filed for PIONERE with the United States Patent and Trademark Office. The USPTO has given the PIONERE trademark a serial number of 77742448. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 4, 2013. This trademark is owned by Glaxo Group Limited. The PIONERE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
pionere

General Information

Serial Number77742448
Word MarkPIONERE
Filing DateThursday, May 21, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 4, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 13, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 26, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 4, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 4, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 30, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2012EXTENSION 5 GRANTED
Tuesday, June 26, 2012EXTENSION 5 FILED
Tuesday, June 26, 2012TEAS EXTENSION RECEIVED
Thursday, January 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2012EXTENSION 4 GRANTED
Tuesday, December 20, 2011EXTENSION 4 FILED
Tuesday, December 20, 2011TEAS EXTENSION RECEIVED
Saturday, June 18, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 17, 2011EXTENSION 3 GRANTED
Wednesday, June 15, 2011EXTENSION 3 FILED
Wednesday, June 15, 2011TEAS EXTENSION RECEIVED
Wednesday, December 8, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 7, 2010EXTENSION 2 GRANTED
Tuesday, November 23, 2010EXTENSION 2 FILED
Tuesday, November 23, 2010TEAS EXTENSION RECEIVED
Tuesday, August 3, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 2, 2010EXTENSION 1 GRANTED
Thursday, July 1, 2010EXTENSION 1 FILED
Monday, August 2, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 1, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 5, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 13, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2009PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, August 26, 2009ASSIGNED TO LIE
Tuesday, August 25, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, August 20, 2009ASSIGNED TO EXAMINER
Tuesday, May 26, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 25, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

pionere pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic